annual retained earnings:
-$1.80B-$465.89M(-34.86%)Summary
- As of today (June 23, 2025), MDGL annual retained earnings is -$1.80 billion, with the most recent change of -$465.89 million (-34.86%) on December 31, 2024.
- During the last 3 years, MDGL annual retained earnings has fallen by -$1.13 billion (-170.07%).
- MDGL annual retained earnings is now -3583.97% below its all-time high of -$48.92 million, reached on December 31, 2015.
Performance
MDGL Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$1.88B-$73.24M(-4.06%)Summary
- As of today (June 23, 2025), MDGL quarterly retained earnings is -$1.88 billion, with the most recent change of -$73.24 million (-4.06%) on March 31, 2025.
- Over the past year, MDGL quarterly retained earnings has dropped by -$391.59 million (-26.39%).
- MDGL quarterly retained earnings is now -3733.68% below its all-time high of -$48.92 million, reached on December 31, 2015.
Performance
MDGL quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MDGL Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.9% | -26.4% |
| 3 y3 years | -170.1% | -158.7% |
| 5 y5 years | -707.4% | -623.1% |
MDGL Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -170.1% | at low | -158.7% | at low |
| 5 y | 5-year | -707.4% | at low | -623.1% | at low |
| alltime | all time | -3584.0% | at low | -3733.7% | at low |
MDGL Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$1.88B(+4.1%) |
| Dec 2024 | -$1.80B(+34.9%) | -$1.80B(+3.4%) |
| Sep 2024 | - | -$1.74B(+6.5%) |
| Jun 2024 | - | -$1.64B(+10.2%) |
| Mar 2024 | - | -$1.48B(+11.0%) |
| Dec 2023 | -$1.34B(+38.8%) | -$1.34B(+9.2%) |
| Sep 2023 | - | -$1.22B(+8.8%) |
| Jun 2023 | - | -$1.13B(+8.3%) |
| Mar 2023 | - | -$1.04B(+8.0%) |
| Dec 2022 | -$962.66M(+44.3%) | -$962.66M(+9.8%) |
| Sep 2022 | - | -$876.75M(+10.2%) |
| Jun 2022 | - | -$795.56M(+9.8%) |
| Mar 2022 | - | -$724.83M(+8.6%) |
| Dec 2021 | -$667.31M(+56.8%) | -$667.31M(+10.7%) |
| Sep 2021 | - | -$602.76M(+11.7%) |
| Jun 2021 | - | -$539.66M(+12.9%) |
| Mar 2021 | - | -$478.01M(+12.4%) |
| Dec 2020 | -$425.46M(+90.6%) | -$425.46M(+16.1%) |
| Sep 2020 | - | -$366.34M(+18.8%) |
| Jun 2020 | - | -$308.38M(+18.9%) |
| Mar 2020 | - | -$259.36M(+16.2%) |
| Dec 2019 | -$223.22M(+60.3%) | -$223.22M(+14.2%) |
| Sep 2019 | - | -$195.48M(+12.3%) |
| Jun 2019 | - | -$174.05M(+12.8%) |
| Mar 2019 | - | -$154.35M(+10.8%) |
| Dec 2018 | -$139.27M(+30.8%) | -$139.27M(+9.0%) |
| Sep 2018 | - | -$127.80M(+7.1%) |
| Jun 2018 | - | -$119.28M(+5.7%) |
| Mar 2018 | - | -$112.83M(+6.0%) |
| Dec 2017 | -$106.46M(+41.4%) | -$106.46M(+8.6%) |
| Sep 2017 | - | -$98.02M(+9.3%) |
| Jun 2017 | - | -$89.65M(+10.3%) |
| Mar 2017 | - | -$81.31M(+8.0%) |
| Dec 2016 | -$75.31M(+53.9%) | -$75.31M(+11.5%) |
| Sep 2016 | - | -$67.56M(-90.6%) |
| Jun 2016 | - | -$716.15M(+0.5%) |
| Mar 2016 | - | -$712.77M(+1357.0%) |
| Dec 2015 | -$48.92M | -$48.92M(-93.0%) |
| Sep 2015 | - | -$695.71M(+2.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | -$678.08M(+3.0%) |
| Mar 2015 | - | -$658.28M(+3.2%) |
| Dec 2014 | -$637.57M(+15.6%) | -$637.57M(+3.3%) |
| Sep 2014 | - | -$617.22M(+3.3%) |
| Jun 2014 | - | -$597.25M(+3.9%) |
| Mar 2014 | - | -$574.97M(+4.3%) |
| Dec 2013 | -$551.41M(+19.6%) | -$551.41M(+4.6%) |
| Sep 2013 | - | -$527.25M(+4.5%) |
| Jun 2013 | - | -$504.74M(+4.7%) |
| Mar 2013 | - | -$481.95M(+4.5%) |
| Dec 2012 | -$461.22M(+15.8%) | -$461.22M(+4.1%) |
| Sep 2012 | - | -$443.10M(+3.5%) |
| Jun 2012 | - | -$428.10M(+3.5%) |
| Mar 2012 | - | -$413.48M(+3.8%) |
| Dec 2011 | -$398.43M(+13.5%) | -$398.43M(+2.8%) |
| Sep 2011 | - | -$387.69M(+3.4%) |
| Jun 2011 | - | -$374.95M(+3.4%) |
| Mar 2011 | - | -$362.45M(+3.2%) |
| Dec 2010 | -$351.05M(+11.9%) | -$351.05M(+2.6%) |
| Sep 2010 | - | -$342.23M(+3.1%) |
| Jun 2010 | - | -$331.96M(+2.8%) |
| Mar 2010 | - | -$322.89M(+3.0%) |
| Dec 2009 | -$313.58M(-20.1%) | -$313.58M(+2.3%) |
| Sep 2009 | - | -$306.55M(-27.8%) |
| Jun 2009 | - | -$424.67M(+2.0%) |
| Mar 2009 | - | -$416.17M(+6.0%) |
| Dec 2008 | -$392.67M(+30.9%) | -$392.67M(+7.1%) |
| Sep 2008 | - | -$366.72M(+7.7%) |
| Jun 2008 | - | -$340.40M(+7.1%) |
| Mar 2008 | - | -$317.70M(+5.9%) |
| Dec 2007 | -$300.05M(+26.8%) | -$300.05M(+5.5%) |
| Sep 2007 | - | -$284.53M(+5.5%) |
| Jun 2007 | - | -$269.65M(+6.6%) |
| Mar 2007 | - | -$252.91M(+6.9%) |
| Dec 2006 | -$236.56M(+31.9%) | -$236.56M(+5.6%) |
| Sep 2006 | - | -$224.07M(+25.0%) |
| Dec 2005 | -$179.29M(+62.4%) | -$179.29M(+39.8%) |
| Mar 2005 | - | -$128.28M |
| Dec 2004 | -$110.42M(+71.2%) | - |
| Dec 2003 | -$64.49M | - |
FAQ
- What is Madrigal Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual retained earnings year-on-year change?
- What is Madrigal Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly retained earnings year-on-year change?
What is Madrigal Pharmaceuticals annual retained earnings?
The current annual retained earnings of MDGL is -$1.80B
What is the all time high annual retained earnings for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual retained earnings is -$48.92M
What is Madrigal Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, MDGL annual retained earnings has changed by -$465.89M (-34.86%)
What is Madrigal Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of MDGL is -$1.88B
What is the all time high quarterly retained earnings for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly retained earnings is -$48.92M
What is Madrigal Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, MDGL quarterly retained earnings has changed by -$391.59M (-26.39%)